Abstract
Astragaloside IV (ASV), which has several pharmacological abilities, shows potential therapeutic effects on certain cancers by regulating the expression of long noncoding RNA (lncRNA). However, the anticancer role that ASV plays by regulating lncRNAs in breast cancer remains unknown. In this study, we first demonstrated that the lncRNA of TRHDE antisense RNA 1 (TRHDE-AS1) was downregulated in breast cancer tissues and cells. Low TRHDE-AS1 expression is associated with poor outcomes in patients with breast cancer and potentially contributes to the aggressive tumor biology of breast cancer. Furthermore, ASV significantly increased TRHDE-AS1 expression in a dose- and time-dependent manner in breast cancer cells. By upregulating TRHDE-AS1, ASV repressed breast cancer cell growth and metastasis both in vitro and in vivo. Taken together, our data indicated that TRHDE-AS1 participates in the anticancer role of ASV in breast cancer, which provides evidence for the application of ASV for breast cancer therapy.
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34
Liu MY, Gou LY, Xia J, Wan Q, Jiang YY, Sun SL et al (2018) LncRNA ITGB2-AS1 could promote the migration and invasion of breast cancer cells through up-regulating ITGB2. Int J Mol Sci 19:1866
Chai F, Liang Y, Bi J, Chen L, Zhang F, Cui YH et al (2014) High expression of REGγ is associated with metastasis and poor prognosis of patients with breast cancer. Int J Clin Exp Pathol 7:7834–7843
Wang N, Liu J, Xie F, Gao X, Ye JH, Sun LY et al (2015) miR-124/ATF-6, a novel lifespan extension pathway of Astragalus polysaccharide in Caenorhabditis elegans. J Cell Biochem 116:242–251
Zhao P, Wang Y, Zeng S, Lu J, Jiang TM, Li YM (2015) Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice. Immunopharmacol Immunotoxicol 37:428–433
Chen Z, Cai Y, Zhang W, Liu X, Liu S (2014) Astragaloside IV inhibits platelet-derived growth factor-BB-stimulated proliferation and migration of vascular smooth muscle cells via the inhibition of p38 MAPK signaling. Exp Ther Med 8:1253–1258
Lin R, Chen H, Callow D, Li S, Wang L, Li S et al (2017) Multifaceted effects of astragaloside IV on promotion of random pattern skin flap survival in rats. Am J Transl Res 9:4161–4172
Du J, Liu J, Zhen J, Yang ST, Zheng EL, Leng JY (2019) Astragaloside IV protects cardiomyocytes from hypoxia-induced injury by down-regulation of lncRNA GAS5. Biomed Pharmacother 116:109028
Li YL, Ye Y, Chen HY (2018) Astragaloside IV inhibits cell migration and viability of hepatocellular carcinoma cells via suppressing long noncoding RNA ATB. Biomed Pharmacother 99:134–141
Qian WB, Cai XR, Qian QH (2020) Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition. Aging (Albany NY) 12:4322–4336
Zhang XQ, Yao C, Bian WH, Chen X, Xue JX, Zhu ZY et al (2019) Effects of astragaloside IV on treatment of breast cancer cells execute possibly through regulation of Nrf2 via PI3K/AKT/mTOR signaling pathway. Food Sci Nutr 7:403–3413
Jiang K, Lu Q, Li Q, Ji YJ, Chen WL, Xue XH (2017) Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling. Int Immunopharmacol 42:195–202
Zheng YF, Dai Y, Liu WP, Wang N, Cai YL, Wang SQ et al (2019) Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage. J Cell Physio 234:4277–4290
Zhuan B, Lu YT, Chen Q, Zhao X, Li P, Yuan Q et al (2019) Overexpression of the long noncoding RNA TRHDE-AS1 inhibits the progression of lung cancer via the miRNA-103/KLF4 Axis. J Cell Biochem 120:17616–17624
Liu SH, Zhu JW, Xu HH, Zhang GQ, Wang Y, Liu YM et al (2017) A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth. Mol Cell Biochem 430:47–56
Anastasiadou E, Jacob LS, Slack FJ (2017) Non-coding RNA networks in cancer. Nat Rev Cancer 18:5–18
Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y et al (2020) Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer 19:47
Torarinsson E, Sawera M, Havgaard JH, Fredholm M, Gorodkin J (2006) Thousands of corresponding human and mouse genomic regions unalignable in primary sequence contain common RNA structure. Genome Res 16:885–889
Kong Q, Liang C, Jin Y, Pan Y, Tong D, Kong Q et al (2019) The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a. Cell Mol Biol Lett 24:26
Zhen Q, Gao LN, Wang RF, Chu WW, Zhang YX, Zhao XJ et al (2018) LncRNA DANCR promotes lung cancer by sequestering miR-216a. Cancer Control 25:1073274818769849
Xu M, Chen X, Lin K, Zeng K, Liu X, Pan B et al (2018) The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer 17:141
Yoshida K, Toden S, Ravindranathan P, Han H, Goel A et al (2017) Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Carcinogenesis 38:1036–1046
Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M et al (2014) Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 5:e1008
Vendramin R, Verheyden Y, Ishikawa H, Goedert L, Nicolas E, Saraf K et al (2018) SAMMSON fosters cancer cell fitness by concertedly enhancing mitochondrial and cytosolic translation. Nat Struct Mol Biol 25:1035–1046
Yin J, Luo W, Zeng X, Zeng L, Li Z, Deng X et al (2017) UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer. Am J Cancer Res 7:462–472
Wang D, Calabrese EJ, Lian B, Lin Z (2018) Hormesis as a mechanistic approach to understanding herbal treatments in traditional Chinese medicine. Calabrese V Pharmacol Ther 184:42–50
Lee YW, Chen TL, Vernon Shih YR, Tsai CL, Chang CC, Liang HH et al (2014) Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study. Cancer 120:1338–1344
Wang S, Zhou T, Zhai JP, Wang LH, Chen J (2014) Effects of modified sanhuang decoction enema on serum tumor necrosis factor-α and colonic mucosa interleukin-1β, interleukin-6 levels in ulcerative colitis rats. Chin J Integr Med 20:865–869
Auyeung KK, Han QB, Ko JK (2016) Astragalus membranaceus: a review of its protection against inflammation and gastrointestinal cancers. Am J Chin Med 44:1–22
Pang B, Wang Q, Ning S, Wu J, Zhang X, Chen Y et al (2019) Landscape of tumor suppressor long noncoding RNAs in breast cancer. J Exp Clin Cancer Res 38:79
Yang F, Lyu SX, Dong SY, Liu YH, Zhang XH, Wang OC (2016) Expression profile analysis of long noncoding RNA in HER-2-enriched subtype breast cancer by next-generation sequencing and bioinformatics. Onco Targets Ther 9:761–772
Yang F, Lv SX, Lv L, Liu YH, Dong SY, Yao ZH et al (2016) Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer. Onco Targets Ther 9:7039–7045
Acknowledgements
This work was supported by grants from Traditional Chinese Medical science and technology plan of Zhejiang Province (2020ZA086, 2020ZQ036).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hu, S., Zheng, W. & Jin, L. Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1. J Nat Med 75, 156–166 (2021). https://doi.org/10.1007/s11418-020-01469-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-020-01469-8